Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled off its GLP-1 throne. In a statement to Reuters, the Danish conglomerate admitted ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

It faces more than 1,800 lawsuits consolidated in federal court in Pennsylvania and new claims emerging weekly, according to ...

GLP-1 weight-loss drugs are creating “mortality slippage” in life insurance which is a costly problem that's forcing insurers to rethink how they underwrite.

Novo Nordisk is to freeze hiring in an effort to control costs at the drug maker. The halt will apply across all markets and ...

A host of women have complained that they are experiencing 'Ozempic vulva' after taking weight loss drugs to shed the pounds.

The hiring freeze will apply across all markets and departments, with the exception of business-critical roles, a spokeswoman said.

A doctor has revealed the truth behind what is being dubbed the 'Ozempic vulva' as the drug surges in popularity.

This is one huge reason to believe in the future of Novo Nordisk (NYSE: NVO), the Danish company behind the immensely popular Wegovy obesity treatment. Last week the company earned a new feather in ...

The weight loss drug, which was previously also used to treat diabetes, may be having an unexpected impact on a rather sensitive body part ...

Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood ...